Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

FEBS Letters
B ChiniC Barberis

Abstract

We investigated the mechanisms that regulate the efficacy of agonists in the arginine-vasopressin (AVP)/oxytocin (OT) receptor system. In this paper, we present evidence that AVP, a full agonist of the vasopressin receptors, acts as a partial agonist on the oxytocin receptor. We also found that AVP becomes a full agonist when two aromatic residues of the oxytocin receptor are replaced by the residues present at equivalent positions in the vasopressin receptor subtypes. Our results indicate that these two residues modulate the response of the oxytocin receptor to the partial agonist AVP.

References

Apr 9, 1992·Nature·T KimuraH Okayama
May 28, 1992·Nature·M BirnbaumerW Rosenthal
Apr 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M MaggiM Serio
Mar 1, 1988·European Journal of Pharmacology·J ElandsW H Sawyer
Oct 1, 1988·American Journal of Obstetrics and Gynecology·M P SchreyP J Steer
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·S MahlmannD Richter
Jan 1, 1995·Annual Review of Medicine·T M FujiwaraD G Bichet
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·S J LolaitM J Brownstein
Jun 1, 1995·Trends in Pharmacological Sciences·T Kenakin
May 26, 1995·The Journal of Biological Chemistry·Y H FengS S Karnik
Aug 1, 1994·Current Opinion in Biotechnology·T W Schwartz
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·F RozenH H Zingg
Oct 1, 1994·European Journal of Endocrinology·T KimuraY Tokugawa
Jan 1, 1994·Annual Review of Biochemistry·C D StraderR A Dixon
Apr 1, 1994·Current Opinion in Cell Biology·J M Baldwin
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·E FriedmanL De Marco
Jan 1, 1993·Trends in Pharmacological Sciences·M F HibertA Bruinvels
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F O LevyL Birnbaumer

❮ Previous
Next ❯

Citations

Jul 23, 2003·European Journal of Pharmacology·Masaki KawamataKatsuhiko Nishimori
Jun 15, 1999·Progress in Neurobiology·F Noble, B P Roques
Jun 27, 2003·Trends in Endocrinology and Metabolism : TEM·Hans H Zingg, Stephane A Laporte
Jul 14, 2010·Nature Chemical Biology·Laura AlbizuThierry Durroux
Nov 24, 1999·European Journal of Biochemistry·E KojroF Fahrenholz
Nov 10, 2011·The Journal of Biological Chemistry·Marta BusnelliBice Chini
Mar 27, 2012·PloS One·Christian W Gruber, Markus Muttenthaler
Apr 28, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·Andrew L SiebelLaura J Parry
Oct 10, 2012·Future Medicinal Chemistry·Christian W GruberMarkus Muttenthaler
Oct 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yuki TakayanagiKatsuhiko Nishimori
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Johannes KoehbachChristian W Gruber
Dec 1, 2007·Expert Opinion on Drug Discovery·Balázs JójártArpád Márki
Dec 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Pedro Vargas-PinillaMaria Cátira Bortolini
Jul 3, 2010·Pharmacology, Biochemistry, and Behavior·Pawel K OlszewskiAllen S Levine
Oct 3, 2014·Endocrine Journal·Hiroshi IwakuraKazuwa Nakao
Apr 17, 2008·The European Journal of Neuroscience·Annegret BlumeInga D Neumann
Jan 11, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Magdalena J SlusarzRafał Slusarz
Feb 13, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Mar 30, 2016·Frontiers in Neuroendocrinology·Jeffrey A FrenchJon Cavanaugh
Jan 10, 2009·The Journal of Comparative Neurology·Cary H LeungDonna L Maney
Oct 11, 2011·Developmental Cognitive Neuroscience·Ilanit GordonJames F Leckman
Jan 30, 2013·Biochemical Society Transactions·Johannes KoehbachChristian W Gruber
Oct 8, 2013·Expert Opinion on Therapeutic Patents·Yang YangTian-Rui Xu
Mar 11, 1999·Journal of Receptor and Signal Transduction Research·M HibertC Barberis
Mar 15, 2013·Molecular Phylogenetics and Evolution·Kaoru Yamashita, Takashi Kitano
Oct 3, 2002·Neuropeptides·J T Winslow, T R Insel
Dec 31, 2002·Journal of Receptor and Signal Transduction Research·E PolitowskaJ Ciarkowsk
Feb 14, 2018·Integrative Zoology·Aaryn MustoeJeffrey A French
Jan 27, 2006·Human Reproduction Update·Hemlata ThackareKate Whittington
Jan 5, 2008·The Journal of Biological Chemistry·Sébastien DutertreRichard J Lewis
May 21, 2019·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·A DayiN Uysal
Nov 10, 2011·Endocrinology·Cary H LeungDonna L Maney
Aug 1, 2019·Annals of the New York Academy of Sciences·Nicole ScholzTorsten Schöneberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.